TIFA enhances glycolysis through E2F1 and promotes the progression of glioma

被引:1
|
作者
Liu, Zhibing [1 ,2 ]
He, Miaolong [3 ]
Yu, Zeshun [1 ]
Ma, Longbo [1 ]
Wang, Xiuwen [2 ]
Ning, Fangling [1 ]
机构
[1] Binzhou Med Univ Hosp, Dept Oncol, 661 Huanghe Second Rd, Binzhou 256603, Shandong, Peoples R China
[2] Shandong Univ, Dept Oncol, Qilu Hosp, 107 Wenhua West Rd, Jinan 256600, Shandong, Peoples R China
[3] Tsinghua Univ, Sch Clin Med, Beijing 100084, Peoples R China
关键词
Glioma; TIFA; Glycolysis; EMT; CANCER;
D O I
10.1016/j.cellsig.2024.111498
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: TRAF interacting protein with forkhead associated domain (TIFA) influence progression of many cancers. However, its role in glioma remains to be explored. This study investigated the function of TIFA in glioma. Methods: The TIFA expression in glioma and patient outcomes were analyzed using online database. Gene set enrichment analysis (GSEA) revealed related mechanisms of TIFA in glioma. TIFA's effects on glioma glycolysis and growth were assessed using in vitro and in vivo experiments. Moreover, luciferase reporter and ChIP were employed to explore the interactions among E2F1, GLUT1, HK2, and LDHA. The subcutaneous xenograft assay further elaborated the effects of TIFA in glioma. Results: We found overexpressed TIFA in glioma. Moreover, the high TIFA expression was associated with poor prognosis of glioma. Furthermore, GSEA indicated that overexpressed TIFA promoted E2F1 and glycolysis. Knockdown of TIFA decreased glioma development in cell and mice. TIFA knockdown down-regulated the expression of E2F1, GLUT1, HK2, and LDHA. Conclusions: The study provides evidence that TIFA regulates E2F1 expression in glioma cells and promotes the proliferation, migration, and glycolysis. TIFA might be an advantageous therapeutic strategy against glioma.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells
    Wu, Minghui
    Seto, Edward
    Zhang, Jingsong
    ONCOTARGET, 2015, 6 (13) : 11252 - 11263
  • [2] SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1
    Gu, Ye
    Wang, Xinling
    Liu, Hong
    Li, Guimei
    Yu, Weiping
    Ma, Qing
    ONCOLOGY REPORTS, 2018, 40 (04) : 1863 - 1874
  • [3] NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer
    Jing, Zuolei
    Liu, Qianmei
    He, Xinyuan
    Jia, Zhirong
    Xu, Zhizhong
    Yang, Bolin
    Liu, Ping
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [4] NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer
    Zuolei Jing
    Qianmei Liu
    Xinyuan He
    Zhirong Jia
    Zhizhong Xu
    Bolin Yang
    Ping Liu
    Journal of Experimental & Clinical Cancer Research, 41
  • [5] E2F1 in Melanoma Progression and Metastasis
    Alla, Vijay
    Engelmann, David
    Niemetz, Annett
    Pahnke, Jens
    Schmidt, Anke
    Kunz, Manfred
    Emmrich, Stephan
    Steder, Marc
    Koczan, Dirk
    Puetzer, Brigitte M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (02): : 127 - 133
  • [6] NCAPD2 promotes breast cancer progression through E2F1 transcriptional regulation of CDK1
    He, Jinsong
    Gao, Rui
    Yang, Jianbo
    Li, Feng
    Fu, Yang
    Cui, Junwei
    Liu, Xiaoling
    Huang, Kanghua
    Guo, Qiuyi
    Zhou, Zihan
    Wei, Wei
    CANCER SCIENCE, 2023, 114 (03) : 896 - 907
  • [7] DTL is a Novel Downstream Gene of E2F1 that Promotes the Progression of Hepatocellular Carcinoma
    Dong, Ruiqiang
    Zhang, Danhua
    Han, Baowei
    Xu, Lingxue
    Zhang, Danfeng
    Cheng, Zhenguo
    Qiu, Xinguang
    CURRENT CANCER DRUG TARGETS, 2023, 23 (10) : 817 - 828
  • [8] MiR-205 enhances cisplatin sensitivity of glioma cells by targeting E2F1
    Li, F. -F.
    Xing, C.
    Wu, L. -L.
    Xue, F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (02) : 299 - 306
  • [9] CHPF promotes gastric cancer tumorigenesis through the activation of E2F1
    Xiaolin Lin
    Ting Han
    Qing Xia
    Jiujie Cui
    Meng Zhuo
    Yiyi Liang
    Wenyu Su
    Lisha Wang
    Liwei Wang
    Zebing Liu
    Xiuying Xiao
    Cell Death & Disease, 12
  • [10] CHPF promotes gastric cancer tumorigenesis through the activation of E2F1
    Lin, Xiaolin
    Han, Ting
    Xia, Qing
    Cui, Jiujie
    Zhuo, Meng
    Liang, Yiyi
    Su, Wenyu
    Wang, Lisha
    Wang, Liwei
    Liu, Zebing
    Xiao, Xiuying
    CELL DEATH & DISEASE, 2021, 12 (10)